Skip to content

Endobon

by Biomet, Inc.

510(k) K980679

Endobon is a medical device (FDA Class II; FDA product code LYC, Bone Grafting Material, Synthetic) made by Biomet, Inc., cleared under FDA 510(k) K980679 on 3 Apr 1998, active as of 22 Oct 2026. One FDA recall is linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK980679 Date3 Apr 1998ClearedStatusActive

Official records

From the FDA record

Received by the FDA
20 Feb 1998
FDA decision
3 Apr 1998 (Substantially Equivalent)
FDA review time
42 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K980679 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

1 recall · FDA

    • Terminated Z-1233-2014 FDA Class III initiated 3 Oct 2013

    Individual pieces of a batch of Biomet's Endobon Xenograft Granules 0.5 ML (Bovine Bone substitute) may have an incorrect label with the wrong batch number.

Timeline

2 dated events

  1. Cleared FDA 510(k) K980679
  2. Recall initiated FDA recalls Z-1233-2014

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
LYC
Device class
Class II
Regulation
21 CFR Part 872.3930
Advisory committee
Dental
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code LYC (Bone Grafting Material, Synthetic).

Other devices from Biomet, Inc.

See all devices from Biomet, Inc. →